Nuclear SMAD4 expression and tumor size were significant independent risk factors affecting the DSS of patients with ccRCC in multivariable Cox proportional analysis, with hazard ratios of 3.70 and 1.71 and P values 0.006 and 0.008, respectively. The gene discussed is SMAD4; the disease is nonpapillary renal cell carcinoma.